Found: 13
Select item for more details and to access through your institution.
LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41531-022-00354-3
- By:
- Publication type:
- Article
Lipid level alteration in human and cellular models of alpha synuclein mutations.
- Published in:
- NPJ Parkinson's Disease, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41531-022-00313-y
- By:
- Publication type:
- Article
The impact of COVID-19 and social distancing on people with Parkinson's disease: a survey study.
- Published in:
- NPJ Parkinson's Disease, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41531-020-00153-8
- By:
- Publication type:
- Article
Urinary proteome profiling for stratifying patients with familial Parkinson's disease.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 3, p. 1, doi. 10.15252/emmm.202013257
- By:
- Publication type:
- Article
Subnormal GM1 in PBMCs: Promise for Early Diagnosis of Parkinson's Disease?
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 21, p. 11522, doi. 10.3390/ijms222111522
- By:
- Publication type:
- Article
Plasma Metabolite Signature Classifies Male LRRK2 Parkinson's Disease Patients.
- Published in:
- Metabolites (2218-1989), 2022, v. 12, n. 2, p. N.PAG, doi. 10.3390/metabo12020149
- By:
- Publication type:
- Article
COVID-19 manifestations in people with Parkinson's disease: a USA cohort.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 3, p. 1107, doi. 10.1007/s00415-021-10784-3
- By:
- Publication type:
- Article
Patterns of TDP‐43 Deposition in Brains with LRRK2 G2019S Mutations.
- Published in:
- Movement Disorders, 2023, v. 38, n. 8, p. 1541, doi. 10.1002/mds.29449
- By:
- Publication type:
- Article
Reply to: "Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations"?
- Published in:
- 2022
- By:
- Publication type:
- Letter
Attitudes Toward Telehealth Services Among People Living With Parkinson's Disease: A Survey Study.
- Published in:
- Movement Disorders, 2022, v. 37, n. 6, p. 1289, doi. 10.1002/mds.28990
- By:
- Publication type:
- Article
Reply to: No Evidence that Glucosylsphingosine Is a Biomarker for Parkinson Disease.
- Published in:
- Movement Disorders, 2022, v. 37, n. 3, p. 654, doi. 10.1002/mds.28936
- By:
- Publication type:
- Article
Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's Disease.
- Published in:
- Movement Disorders, 2022, v. 37, n. 2, p. 416, doi. 10.1002/mds.28846
- By:
- Publication type:
- Article
Analysis of Heterozygous PRKN Variants and Copy‐Number Variations in Parkinson's Disease.
- Published in:
- Movement Disorders, 2021, v. 36, n. 1, p. 178, doi. 10.1002/mds.28299
- By:
- Publication type:
- Article